Loading clinical trials...
Loading clinical trials...
Randomised, Open Label, Multicentre, Non-inferiority Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan
Conditions
Interventions
drug: miltefosine with thermotherapy
Locations
2
Pakistan
Kuchlak Primary Health Care Centre (MCH)
Kuchlagh, Balochistan, Pakistan
Shaheed Mohtarma Benazir Bhutto General Hospital
Quetta, Balochistan, Pakistan
Start Date
October 7, 2022
Primary Completion Date
December 31, 2025
Completion Date
January 31, 2026
Last Updated
May 9, 2025
Lead Sponsor
Medecins Sans Frontieres, Netherlands
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions